Akadeum
Akadeum Life Sciences Raises $17.5M in Series B Round
Akadeum will use the funding to further global commercialization of its microbubble-based separation platform and to develop more business capabilities.
Akadeum, NanoCellect Biomedical Partner to Enhance Rare-Cell Workflows
Akadeum's microbubble technology and NanoCellect's Wolf cell-sorting platform will be integrated for high-quality single-cell sequencing of rare cell types.
More groups are now using CTC capture methods alongside circulating tumor DNA tools to distinguish themselves from the crowded ctDNA detection space.
Sample Prep Firm Akadeum Life Sciences Raises $4M
The firm did an initial close of its Series A financing round and will pursue additional investments during Q1 2020 when the round is anticipated to close.
Research groups and companies are developing and applying tools to enrich for and capture CTCs to diagnose tumors early and monitor patients during treatment.